Man behind GcMaf set to lose aircraft and luxury cars

He could now face losing his aircraft and luxury cars.

He has previously been convicted and jailed for offences related to unlicensed medicine and money laundering, in connection with the substance GcMAF, which he claimed was a cure for cancer, HIV, autism and other conditions.

He was returned to jail just a few weeks ago, after skipping bail and going on the run for five months.

Now a judge at Southwark Crown Court has ordered the seizure of £1.4m.

A statement from the UK Government states that the disgraced company owner now faced the seizure of his aircraft, boat, Aston Martin and Rolls-Royce, as well as his UK and Guernsey bank accounts.

The outcome follows a four-year investigation by the Medicines and Healthcare products Regulatory Agency, which was assisted by the London Regional Asset Recovery Team in investigating Mr Noakes’s complex financial dealings.

Mr Noakes, the owner of Guernsey-based Immuno Biotech, served a 15-month prison sentence from November 2018 after pleading guilty to four charges relating to the manufacture, sale and supply of an unlicensed medicine, GcMAF, and one count of money laundering.

Globulin component Macrophage Activating Factor (GcMAF) was a product made from human blood, sold by Immuno Biotech.

The court heard Noakes made more than £13m. from the sale of GcMAF between 2011 and 2015.

It was sold through various European websites which UK buyers would have had no difficulty accessing. Production was stopped in January 2015, as a result of the MHRA’s investigation, and more than 10,000 vials were seized, which Noakes could have sold for £5.5m. The MHRA also issued a warning to the public against purchasing GcMAF.

The £1,349,400.48 confiscation order means that the identified assets will be realised and paid to the Home Office for distribution under the Proceeds of Crime Act, 2002 incentivisation scheme.

MHRA head of enforcement, Andy Morling, said the confiscation marked a successful end to a complex investigation.

‘Our investigation team has worked relentlessly to bring David Noakes and his associates to justice and today’s decision to deny him the proceeds of his criminality is welcome,’ he said on Friday.

‘Noakes put public health at risk through the unlicensed manufacturing and sale of GcMAF products, which were not fit for human consumption or for use as medicines.'

‘To get the best advice in relation to your health, visit your GP or other health professional, get a correct diagnosis and always buy medicines from a legitimate high street or registered pharmacy.’

He advised the public to only buy medicines online from registered websites.

‘Patient safety is our highest priority and we will continue to track, prosecute and remove assets from criminals who exploit public health for their own gain,’ Mr Morling said.

The former Immuno Biotech boss is facing nine charges under a European Arrest Warrant in relation to the sale and distribution of GcMAF from France.